首页|术前应用右美托咪定影响冠状动脉旁路移植术后新发心房颤动的倾向性评分匹配分析

术前应用右美托咪定影响冠状动脉旁路移植术后新发心房颤动的倾向性评分匹配分析

扫码查看
目的 探讨行冠状动脉旁路移植术患者术前应用右美托咪定与地西泮后心房颤动(房颤)发生率的差异.方法 采用回顾性队列研究方法,纳入2020年10月—2021年6月于中国人民解放军北部战区总医院行冠状动脉旁路移植术的患者.通过倾向性评分匹配分析法,比较冠状动脉旁路移植术患者术前应用右美托咪定(右美托咪定组)与地西泮(地西泮组)后房颤发生率.结果 纳入207例患者,其中男150例、女57例,平均年龄(62.02±8.38)岁.术前应用右美托咪定患者53例,术前应用地西泮患者154例.匹配前两组高血压患者占比、吸烟患者占比差异有统计学意义(P<0.05).按1∶1倾向性匹配后,两组各纳入53例患者,两组数据分布均匀.匹配后,右美托咪定组术后房颤发生率较地西泮组低[9.43%(5/53)vs.30.19%(16/53),P=0.007].两组患者住院期间均无死亡,术后主要不良事件无明显差别,且右美托咪定组监护室停留时间[(21.28±2.69)hvs.(22.80± 2.56)h,P=0.004]及机械通气时间[(18.53±2.25)hvs.(19.85±2.01)h,P=0.002]更短.回归分析发现,年龄、吸烟、糖尿病与术后房颤发生率上升有关(P<0.05);术前使用右美托咪定与术后房颤发生率降低有关(P=0.002).结论 对行冠状动脉旁路移植术的患者,术前应用右美托咪定较地西泮术后房颤发生率低.术前应用右美托咪定是术后房颤的保护因素,高龄、吸烟和糖尿病是术后房颤的危险因素.
Effect of preoperative application of dexmedetomidine on atrial fibrillation after coronary artery bypass grafting:A propensity score-matching analysis
Objective To evaluate the incidence of postoperative atrial fibrillation(POAF)after dexmede-tomidine and diazepam in patients undergoing coronary artery bypass grafting(CABG).Methods A retrospective cohort study was conducted in the patients who underwent CABG in the General Hospital of Northern Theater Command from October 2020 to June 2021.By propensity score-matching method,the incidence of POAF after dexmedetomidine and diazepam application in patients undergoing CABG was evaluated.Results Finally 207 patients were collected,including 150 males and 57 females,with an average age of 62.02±8.38 years.Among the 207 patients,53 were treated with dexmedetomidine and 154 with diazepam before operation.There was a statistical difference in the proportion of hypertension patients and smoking patients between the two groups before matching(P<0.05).According to the 1∶1 propensity score-matching method,there were 53 patients in each of the two groups,with no statistical difference between the two groups after matching.After matching,the incidence of POAF in the dexmedetomidine group was lower than that in the diazepam group[9.43%(5/53)vs.30.19%(16/53),P=0.007].There was no death in the two groups during hospitalization,and there was no statistical difference in the main adverse events after operation.The ICU stay(21.28±2.69 h vs.22.80±2.56 h,P=0.004)and mechanical ventilation time(18.53±2.25 h vs.19.85±2.01 h,P=0.002)in the dexmedetomidine group were shorter.Regression analysis showed that age,smoking and diabetes were related to the increased incidence of POAF(P<0.05),and preoperative use of dexmedetomidine was associated with a reduced incidence of POAF(P=0.002).Conclusion For patients undergoing CABG,the incidence of POAF with dexmedetomidine before operation is lower than that with diazepam.Preoperative application of dexmedetomidine is the protective factor for POAF,and old age,smoking and diabetes are the risk factors for POAF.

Coronary artery bypass graftingatrial fibrillationdexmedetomidinediazepampropensity score-matching analysis

郭志鹏、张建、李瑞、梁汉青、刘竹贤、辛芳冉、尹宗涛、韩劲松

展开 >

中国医科大学北部战区总医院研究生培养基地(沈阳 110016)

中国人民解放军北部战区总医院心血管外科(沈阳 110016)

沈阳药科大学(沈阳 110016)

冠状动脉旁路移植术 心房颤动 右美托咪定 地西泮 倾向性评分匹配分析

2024

中国胸心血管外科临床杂志
四川大学华西医院

中国胸心血管外科临床杂志

CSTPCD北大核心
影响因子:0.846
ISSN:1007-4848
年,卷(期):2024.31(3)
  • 28